MichalGillianRoseMD
Oncology • West Haven, CTHematologic Oncology
Associate Professor, Comprehensive Cancer Center, Yale University School of Medicine
Dr. Rose is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
950 Campbell Ave
West Haven, CT 06516Phone+1 203-937-3421Fax+1 203-937-3803
Education & Training
Yale-New Haven Medical CenterResidency, Internal Medicine, 1998 - 1999
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 1993 - 1996
The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1987
Certifications & Licensure
CT State Medical License 1993 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Start of enrollment: 2004 Jan 01
- A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer Start of enrollment: 2008 Dec 01
Publications & Presentations
PubMed
- 348 citationsSystemic Therapy for Advanced Hepatocellular Carcinoma: ASCO GuidelineJohn D. Gordan, Erin B. Kennedy, Ghassan K. Abou-Alfa, Muhammad Shaalan Beg, Steven Brower
Journal of Clinical Oncology. 2020-11-16 - 32 citationsRRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancerDaniel Morgensztern, Michal G. Rose, Saiama N. Waqar, John C. Morris, Patrick C. Ma
British Journal of Cancer. 2019-07-30 - 44 citationsTime trends in glioblastoma multiforme survival: the role of temozolomideRobert Dubrow, Amy S. Darefsky, Daniel I. Jacobs, Lesley S. Park, Michal G. Rose
Neuro-Oncology. 2013-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
